Latest News of ABBV
AbbVie Inc. (NYSE:ABBV) is largely controlled by institutional shareholders who own 73% of the company
By Yahoo! Finance | 2 months ago
Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform
By MarketWatch | 3 months ago
Is AbbVie Inc. (ABBV) the Best Dividend Aristocrat Stock To Buy Right Now?
By Yahoo! Finance | 3 months ago
Here are Friday's biggest analyst calls: Nvidia, Apple, Nike, Microsoft, Flutter, Amazon, Arm, Affirm, AbbVie & more
By CNBC | 3 months ago
AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year
By Yahoo! Finance | 3 months ago
Why AbbVie's (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment
By Yahoo! Finance | 3 months ago
AbbVie's stock plummets over 12% after schizophrenia drug flops in Phase II trials
By Yahoo! Finance | 4 months ago
Bristol Myers's stock soars after AbbVie's schizophrenia-drug trial disappoints
By MarketWatch | 4 months ago
AbbVie Stock Tumbles on Failed Schizophrenia Drug Studies. Bristol Myers Jumps.
By MarketWatch | 4 months ago
Wall Street Bulls Look Optimistic About AbbVie (ABBV): Should You Buy?
By Yahoo! Finance | 4 months ago